Abbott India Limited (NSE:ABBOTINDIA)
India flag India · Delayed Price · Currency is INR
30,170
+5 (0.02%)
May 12, 2025, 2:30 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Pharmaceuticals
58.49B
Log In
Log In
Log In
Log In
Pharmaceuticals Growth
9.35%
Log In
Log In
Log In
Log In
Injectables
-
Log In
Log In
Log In
Log In
Injectables Growth
-
Log In
Log In
Log In
Log In
Tablets
-
Log In
Log In
Log In
Log In
Tablets Growth
-
Log In
Log In
Log In
Log In
Liquids
-
Log In
Log In
Log In
Log In
Liquids Growth
-
Log In
Log In
Log In
Log In
Capsules
-
Log In
Log In
Log In
Log In
Capsules Growth
-
Log In
Log In
Log In
Log In
Services
-
Log In
Log In
Log In
Log In
Services Growth
-
Log In
Log In
Log In
Log In
Other Product
-
Log In
Log In
Log In
Log In
Other Product Growth
-
Log In
Log In
Log In
Log In
Ointments
-
Log In
Log In
Log In
Log In
Ointments Growth
-
Log In
Log In
Log In
Log In
Granules
-
Log In
Log In
Log In
Log In
Granules Growth
-
Log In
Log In
Log In
Log In
Powder
-
Log In
Log In
Log In
Log In
Powder Growth
-
Log In
Log In
Log In
Log In
Other
-
Log In
Log In
Log In
Log In
Other Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
India
57.02B
Log In
Log In
Log In
Log In
India Growth
9.34%
Log In
Log In
Log In
Log In
International
782.70M
Log In
Log In
Log In
Log In
International Growth
11.35%
Log In
Log In
Log In
Log In